59
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex

, , , &
Pages 13-16 | Published online: 25 Nov 2022

References

  • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials–TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study GroupArch Ophthalmol19991171329134510532441
  • GroupTSPhotodynamic therapy of subfoveal choroidal neovascularization in age?related macular degeneration with verteporfin: Two-years results of 2 randomized clinical trials-TAP report 2Arch Ophthalmol200111919820711176980
  • KozakIChengLCochranDEFreemanWRPhase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degenerationBr J Ophthalmol2006901152115616774958
  • PiermarocchiSLo GiudiceGSartoreMPhotodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degenerationAm J Ophthalmol200213357257511931801
  • StaurenghiGOrzalesiNLa CapriaAAscheroMLaser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiographyOphthalmology1998105229723059855163
  • StaurenghiGMassacesiAMusiccoISalvettiPViolaFCombining photodynamic therapy and feeder vessel photocoagulation: A pilot studySemin Ophthalmol20011623323615513446
  • FineHFPhotodynamic therapy in the anti-VEGF eraBr J Ophthalmol20079170770817510474
  • BrownDMRegilloCDAnti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patientsAm J Ophthalmol200714462763717893015
  • PieramiciDJRabenaMDAnti-VEGF therapy: comparison of current and future agentsEye2008221330133618497829
  • CostaRAJorgeRCalucciDMeloLAJrCardilloJAScottIUIntravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study)Graefes Arch Clin Exp Ophthalmol20072451273128017333238
  • AhmadiehHTaeiRSoheilianMRiazi-EsfahaniMAhadiHSingle-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degenerationEur J Ophthalmol20081829730018320527
  • MillerJWSchmidt-ErfurthUSickenbergMPhotodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 studyArch Ophthalmol19991171161117310496388
  • Schmidt-ErfurthUMichelsSBarbazettoILaquaHPhotodynamic effects on choroidal neovascularization and physiological choroidInvest Ophthalmol Vis Sci20024383084111867605
  • SickenbergMBalliniJPvan den BerghH[Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options]J Fr Ophtalmol2004279310214968086